Cart
sales@molnova.com
Soretolide
CAS No. 130403-08-6
Soretolide( —— )
Catalog No. M36973 CAS No. 130403-08-6
Soretolide (D2916) is a small molecule compound that is used to treat epilepsy.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 296 | Get Quote |
|
| 5MG | 409 | Get Quote |
|
| 10MG | 604 | Get Quote |
|
| 25MG | 908 | Get Quote |
|
| 50MG | 1251 | Get Quote |
|
| 100MG | 1647 | Get Quote |
|
| 500MG | 3312 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameSoretolide
-
NoteResearch use only, not for human use.
-
Brief DescriptionSoretolide (D2916) is a small molecule compound that is used to treat epilepsy.
-
DescriptionSoretolide (D2916) is a small molecule compound that is used to treat epilepsy.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number130403-08-6
-
Formula Weight230.26
-
Molecular FormulaC13H14N2O2
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(NC=1C=C(C)ON1)(=O)C2=C(C)C=CC=C2C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Tetrahydrozoline HCl
Tetrahydrozoline HCl is an imidazoline derivative with alpha receptor agonist activity.
-
Calmodulin Binding P...
Calmodulin Binding Peptide 1 is a high affinity (pM) CaM-binding peptide derived from smooth muscle myosin light-chain kinase (MLCK peptide), which strongly inhibits IP3-induced Ca2+ release .
-
Amatuximab
Amatuximab (MORab-009) is a humanized chimeric IgG1/k monoclonal antibody targeting cell surface mesothelin (MSLN) with antitumor activity for the treatment of solid tumors.
